Clinical Trial Update: A Phase II Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants [Phase 2]

View source ↗

Summary

Phase II trial evaluating the immunogenicity and safety of an inactivated EV71 vaccine (Vero cell-derived) in Chinese children and infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Foot and Mouth Disease

Drugs mentioned

• EV71 vaccine (inactivated, Vero cell-derived) (enterovirus 71 vaccine, inactivated, Vero cell-derived)

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Immunogenicity, Safety | Phase 2 | Status: COMPLETED